LAURA ALVAREZ: Open Payments
NPI 1093997371 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,971 in 94 payments from 26 companies in 2025. Trend: 2023 $1,245 · 2024 $3,977 · 2025 $6,971
Food & beverage: $6,887Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $827 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $780 |
| ABBVIE INC. | 8 | $589 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $526 |
| Abbott Laboratories | 3 | $444 |
| Axsome Therapeutics, Inc. | 4 | $430 |
| Ardelyx, Inc. | 12 | $374 |
| Janssen Biotech, Inc. | 7 | $341 |
| Phathom Pharmaceuticals, Inc. | 11 | $313 |
| Otsuka America Pharmaceutical, Inc. | 2 | $250 |
Products named: REZDIFFRA, ENTYVIO, RINVOQ, FREESTYLE LIBRE 3, Auvelity, IBSRELA, TREMFYA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
